Glycemic Optimization Treatment Study
NCT00552370
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
5062
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Lantus®
Sponsor
Sanofi